Condition
Mesothelioma
Estimated Enrollment: 40
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 16-549
Study First Received: March 2, 2017
Last Updated: April 20, 2017
Estimated Primary Completion Date: September 30, 2020
Primary Outcome Measures:
Overall Response Rate|Overall Survival|Progression Free Survival|Duration of Response|Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Sponsors and Collaborators:
Dana-Farber Cancer Institute|AstraZeneca
Website Link: https://ClinicalTrials.gov/show/NCT03075527
